ATP13A2 and Parkinson disease: ATP13A2, a lysosomal transmembrane cation transporter, linked to an early-onset form of Parkinson’s Disease (PD) when loss-of-function mutations disrupt its function Dehay et al. (2012); Ramirez et al. (2006); Zhang et al. (2022).